The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBurford Capital Regulatory News (BUR)

Share Price Information for Burford Capital (BUR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,259.00
Bid: 1,250.00
Ask: 1,258.00
Change: 0.00 (0.00%)
Spread: 8.00 (0.64%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,259.00
BUR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Private Offering of Senior Notes

24 Mar 2021 12:00

RNS Number : 3485T
Burford Capital Limited
24 March 2021
 

 

 

24 March 2021

 

 

BURFORD CAPITAL ANNOUNCES PRIVATE OFFERING OF SENIOR NOTES

 

Burford Capital Limited ("Burford" or "Burford Capital"), the leading global finance and asset management firm focused on law, today announces the planned private offering of $350 million aggregate principal amount of senior notes due 2028 (the "Notes") by its indirect, wholly owned subsidiary, Burford Capital Global Finance LLC, subject to market and other conditions. The Notes will be guaranteed on a senior unsecured basis by Burford Capital as well as Burford Capital Finance LLC and Burford Capital PLC, both indirect, wholly owned subsidiaries of Burford Capital (such guarantees, together with the Notes, the "Securities").

 

Burford Capital intends to use the net proceeds from the offering for general corporate purposes.

 

The Securities have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), or the laws of any other jurisdiction, and may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons absent registration or an applicable exemption from registration under the Securities Act or any applicable state securities laws. The Securities will be offered only to persons reasonably believed to be "Qualified Institutional Buyers" within the meaning of Rule 144A under the Securities Act or non-U.S. persons outside the United States pursuant to Regulation S under the Securities Act, in each case, who are "Qualified Purchasers" as defined in Section (2)(a)(51)(A) under the U.S. Investment Company Act of 1940.

 

 

For further information, please contact:

 

Burford Capital Limited

Jim Kilman, Chief Financial Officer

+1 917 985 9840

Robert Bailhache, Head of Investor Relations, EMEA and Asia - email

+44 (0)20 3530 2023

Jim Ballan, Head of Investor Relations, Americas - email

+1 (646) 793 9176

Numis Securities Limited - NOMAD and Joint Broker

+44 (0)20 7260 1000

Kevin Cruickshank (NOMAD)

Charlie Farquhar / Jonathan Abbott (Joint Broker)

Jefferies International Limited - Joint Broker

+44 (0)20 7029 8000

Graham Davidson

Tony White

 

About Burford Capital

Burford Capital is the leading global finance and asset management firm focused on law. Its businesses include litigation finance and risk management, asset recovery and a wide range of legal finance and advisory activities. Burford is publicly traded on the New York Stock Exchange (NYSE: BUR) and the London Stock Exchange (LSE: BUR), and it works with companies and law firms around the world from its principal offices in New York, London, Chicago, Washington, Singapore and Sydney.

This communication shall not constitute an offer to sell or the solicitation of an offer to buy any securities of Burford.

 

This release does not constitute an offer of any Burford fund. Burford Capital Investment Management LLC ("BCIM"), which acts as the fund manager of all Burford funds, is registered as an investment adviser with the U.S. Securities and Exchange Commission. The information provided herein is for informational purposes only. Past performance is not indicative of future results. The information contained herein is not, and should not be construed as, an offer to sell or the solicitation of an offer to buy any securities (including, without limitation, interests or shares in the funds). Any such offer or solicitation may be made only by means of a final confidential Private Placement Memorandum and other offering documents.

PRIIPs Regulation / Prohibition of sales to EEA retail investors. The securities described in this announcement are not intended to be offered, sold or otherwise made available to and should not be offered, sold or otherwise made available to any retail investor in the European Economic Area ("EEA"). For these purposes, a retail investor means a person who is one (or more) of: (i) a retail client as defined in point (11) of Article 4(1) of Directive 2014/65/EU (as amended, "MiFID II"); or (ii) a customer within the meaning of Directive 2016/97/ EU (the "Insurance Distribution Directive"), where that customer would not qualify as a professional client as defined in point (10) of Article 4(1) of MiFID II. Consequently no key information document required by Regulation (EU) No 1286/2014 (as amended, the "PRIIPs Regulation") for offering or selling the securities described in this announcement or otherwise making them available to retail investors in the EEA has been prepared and therefore offering or selling the securities described in this announcement or otherwise making them available to any retail investor in the EEA may be unlawful under the PRIIPs Regulation.

 

Prohibition of sales to UK retail investors. The securities described in this announcement are not intended to be offered, sold or otherwise made available to and should not be offered, sold or otherwise made available to any retail investor in the United Kingdom ("UK"). For these purposes, a retail investor means a person who is one (or more) of: (i) a retail client, as defined in point (8) of Article 2 of Regulation (EU) No 2017/565 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018 ("EUWA"); or (ii) a customer within the meaning of the provisions of the FSMA and any rules or regulations made under the FSMA to implement Directive (EU) 2016/97, where that customer would not qualify as a professional client, as defined in point (8) of Article 2(1) of Regulation (EU) No 600/2014 as it forms part of domestic law by virtue of the EUWA. Consequently no key information document required by Regulation (EU) No 1286/2014 as it forms part of domestic law by virtue of the EUWA (the "UK PRIIPs Regulation") for offering or selling the securities described in this announcement or otherwise making them available to retail investors in the UK has been prepared and therefore offering or selling the securities described in this announcement or otherwise making them available to any retail investor in the UK may be unlawful under the UK PRIIPs Regulation.

 

IN MEMBER STATES OF THE EUROPEAN ECONOMIC AREA, THIS ANNOUNCEMENT IS DIRECTED ONLY AT PERSONS WHO ARE "QUALIFIED INVESTORS" WITHIN THE MEANING OF PROSPECTUS REGULATION (EU) 2017/1129 IN SUCH MEMBER STATE, AND SUCH OTHER PERSONS AS THIS DOCUMENT MAY BE ADDRESSED ON LEGAL GROUNDS, AND NO PERSON THAT IS NOT A RELEVANT PERSON OR QUALIFIED INVESTOR MAY ACT OR RELY ON THIS DOCUMENT OR ANY OF ITS CONTENTS. IN THE UK, THIS ANNOUNCEMENT IS DIRECTED ONLY AT PERSONS WHO ARE "QUALIFIED INVESTORS" WITHIN THE MEANING OF PROSPECTUS REGULATION (EU) 2017/1129 AS IT FORMS PART OF DOMESTIC LAW BY VIRTUE OF THE EUWA IN THE UK, AND SUCH OTHER PERSONS AS THIS DOCUMENT MAY BE ADDRESSED ON LEGAL GROUNDS, AND NO PERSON THAT IS NOT A RELEVANT PERSON OR QUALIFIED INVESTOR MAY ACT OR RELY ON THIS DOCUMENT OR ANY OF ITS CONTENTS.

Forward-looking statements

This announcement contains "forward-looking statements" within the meaning of Section 21E of the US Securities Exchange Act of 1934 regarding assumptions, expectations, projections, intentions and beliefs about future events. These statements are intended as "forward-looking statements". In some cases, predictive, future-tense or forward-looking words such as "aim", "anticipate", "believe", "continue", "could", "estimate", "expect", "forecast", "guidance", "intend", "may", "plan", "potential", "predict", "projected", "should" or "will" or the negative of such terms or other comparable terminology are intended to identify forward-looking statements, but are not the exclusive means of identifying such statements. In addition, we and our representatives may from time to time make other oral or written statements which are forward-looking statements, including in our periodic reports that we file with the US Securities and Exchange Commission, other information sent to our security holders, and other written materials. By their nature, forward-looking statements involve known and unknown risks, uncertainties and other factors because they relate to events and depend on circumstances that may or may not occur in the future. We caution you that forward-looking statements are not guarantees of future performance and are based on numerous assumptions and that our actual results of operations, including our financial condition and liquidity and the development of the industry in which we operate, may differ materially from (and be more negative than) those made in, or suggested by, the forward-looking statements contained in this report. Significant factors that may cause actual results to differ from those we expect include those discussed under "Risk Factors" in our Annual Report on Form 20-F filed with the US Securities and Exchange Commission on March 24, 2021. In addition, even if our results of operations, including our financial condition and liquidity and the development of the industry in which we operate, are consistent with the forward-looking statements contained in this report, those results or developments may not be indicative of results or developments in subsequent periods.

 

Except as required by law, we undertake no obligation to update or revise the forward-looking statements contained in this report, whether as a result of new information, future events, a change in our views or expectations or otherwise.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRUSUARAWUOUAR
Date   Source Headline
24th May 20227:00 amRNSPurchases of Shares for Employee Compensation Plan
23rd May 20227:00 amRNSPurchases of Shares for Employee Compensation Plan
20th May 20225:38 pmRNSResult of AGM
20th May 20224:17 pmRNSPricing of Early Redemption of Bonds Due 2022
20th May 20227:00 amRNSPurchases of Shares for Employee Compensation Plan
19th May 20227:00 amRNSPurchases of Shares for Employee Compensation Plan
18th May 20228:00 amRNSNotice of Retail Shareholder Call on June 16, 2022
18th May 20227:00 amRNSPurchases of Shares for Employee Compensation Plan
17th May 20227:00 amRNSPurchases of Shares for Employee Compensation Plan
16th May 20227:00 amRNSPurchases of Shares for Employee Compensation Plan
13th May 20227:00 amRNSPurchases of Shares for Employee Compensation Plan
10th May 20228:00 amRNSNotice of Early Redemption of Bonds Due 2022
19th Apr 20227:00 amRNSAccess to Summary Judgment Filings in YPF Cases
13th Apr 20225:39 pmRNSCompleted Share Purchase by Employee Benefit Trust
13th Apr 202212:00 pmRNSNotice of 2022 AGM
12th Apr 20227:00 amRNSClosing of Private Offering of Senior Notes
11th Apr 20227:00 amRNSChristopher A. Halmy Nominated as Board Director
8th Apr 202211:30 amRNSDirector/PDMR Shareholding
7th Apr 20227:05 amRNSPricing and Upsizing of Senior Notes Offering
6th Apr 202211:30 amRNSDirector/PDMR Shareholding
4th Apr 20221:15 pmRNSPrivate Offering of Senior Notes
4th Apr 20227:00 amRNSManagement Team Invest $3 Million in Burford Stock
1st Apr 20225:59 pmRNSIntended Purchases of Ordinary Shares
29th Mar 202212:43 pmRNSAvailability of Annual Report
29th Mar 202212:13 pmRNSFull Year Results 2021
28th Mar 20227:00 amRNS$360m Pre-Settlement Investment Fund Close
15th Mar 202212:00 pmRNSNotice of FY21 Earnings Call Details
4th Mar 202212:00 pmRNSNotice of FY21 Results & Earnings Call
1st Mar 20224:53 pmRNSBurford Capital - $100m Equity Project Commitments
15th Feb 20227:00 amRNSUpdate on 2021 Business Activity & Accounting
8th Feb 20223:10 pmRNSBurford Capital's Affirmative Recovery Research
19th Jan 20224:30 pmRNSTR1 - Notification of Major Holdings
24th Dec 202110:00 amRNSTR1 - Notification of Major Holdings
23rd Dec 20217:00 amRNSStatement concerning non-cash accrual
15th Nov 20213:00 pmRNSSterling FX Rate for 2021 Interim Dividend
3rd Nov 20212:00 pmRNSDirector/PDMR Shareholding
2nd Nov 202111:57 amRNSMaterials for Investor Event
12th Oct 20212:00 pmRNSNotice of Investor Event Registration Details
27th Sep 202111:00 amRNSDirector/PDMR Shareholding
27th Sep 20218:30 amRNSCompleted Share Purchase by Employee Benefit Trust
20th Sep 20218:30 amRNSDirector/PDMR Shareholding
17th Sep 20218:30 amRNSDirector/PDMR Shareholding
16th Sep 20218:30 amRNSIntended Share Purchase by Employee Benefit Trust
16th Sep 20217:00 amRNSCompleted Share Purchase for NED Share Plan
15th Sep 202111:00 amRNSDirector/PDMR Shareholding
15th Sep 20218:30 amRNSIntended Share Purchase for NED Share Plan
9th Sep 202112:12 pmRNSNotice of Investor Event Date
9th Sep 202112:12 pmRNSInterim Results for six months ended 30 June 2021
26th Aug 20213:00 pmRNSNotice of 1H21 Results Call Registration Details
23rd Aug 20217:00 amRNSBusiness Performance Update and US GAAP Conversion

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.